2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
4
Thoracic
3
Head & Neck
2
Genitourinary
1
Endocrine
1
Classical hematology
1
Breast
1
Conditions
Breast Neoplasms
13138
Triple Negative Breast Neoplasms
1150
Neoplasms
750
Ovarian Neoplasms
680
Neoplasm Metastasis
590
Lung Neoplasms
582
Colorectal Neoplasms
581
Prostatic Neoplasms
560
Carcinoma, Non-Small-Cell Lung
536
Pancreatic Neoplasms
380
Melanoma
366
Stomach Neoplasms
350
Colonic Neoplasms
330
Motor Activity
285
Breast Neoplasms, Male
285
Carcinoma, Intraductal, Noninfiltrating
277
Uterine Cervical Neoplasms
267
Head and Neck Neoplasms
266
Endometrial Neoplasms
256
Carcinoma, Renal Cell
216
Sarcoma
204
Urinary Bladder Neoplasms
192
Squamous Cell Carcinoma of Head and Neck
192
Lymphedema
190
Esophageal Neoplasms
189
Breast Carcinoma In Situ
189
Brain Neoplasms
183
Fatigue
166
Carcinoma, Ovarian Epithelial
151
Small Cell Lung Carcinoma
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Substance-Related Disorders
×
Breast
×
Clear all
NCT03371732
2022-12-02
ONKODETOX
Institut Bergonié
Phase NA
Completed
104 enrolled
48 charts